Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VRCA stock hub

Verrica Pharmaceuticals Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VRCAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

137.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VRCA

In the news

Latest news · VRCA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-240.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-23.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VRCA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001660334
Company name	Verrica Pharmaceuticals Inc.
Country	United States
Country code	US
Cusip	92511W207
Employees	76
Employees Change	5%
Employees Change Percent	7.04
Enterprise value	$108.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-06-15
Isin	US92511W2070
Last refreshed	2026-05-10
Market cap	$137.3M
Market cap category	Micro-Cap
Price	$7.99
Price currency	USD
Rev Per Employee	468,118.42x
Sector	Healthcare
Sic	2834
Symbol	VRCA
Website	https://www.verrica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.03%
EV Sales Forward	4.29x
EV/Sales	3.06x
FCF yield	-12.84%
P/B ratio	5.55x
P/S ratio	3.86x
PS Forward	5.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-33.56%
EBITDA Margin	-32.19%
Gross margin	65.44%
Gross Profit	$23.3M
Net Income	$-17.9M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-50.27%
Profit Margin	-50.27%
Profit Per Employee	$-235,342
ROA	-14.74
Roa5y	-36.86
ROCE	-38.9
ROE	-240.4
Roe5y	-437.1
ROIC	-23.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	95.54%
Cagr3y	-50.4%
Cagr5y	-41.34%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth	370.22x
Revenue Growth Q	1,380.23x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	57.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.7
Assets	$47.1M
Cash	$30.1M
Current Assets	$42.5M
Current Liabilities	$16.4M
Debt	$1.6M
Debt Equity	$0.07
Equity	$24.7M
Interest Coverage	-1.54
Liabilities	$22.4M
Long Term Assets	$4.6M
Long Term Liabilities	$6M
Net Cash	$28.5M
Net Cash By Market Cap	$20.78
Net Cash Growth	7,211.79%
Net Debt Equity	$-1.15
Tangible Book Value	$24.7M
Tangible Book Value Per Share	$1.44
WACC	17.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.59
Inventory Turnover	5.23
Net Working Capital	$-3.3M
Quick ratio	2.16
Working Capital	$26.1M
Working Capital Turnover	$1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-105.61%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	95.45%
200-day SMA	5.9
3Y total return	-87.8%
50-day SMA	5.94
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.05%
All Time High	232.9
All Time High Change	-96.57%
All Time High Date	2018-06-20
All Time Low	3.28
All Time Low Change	143.6%
All Time Low Date	2025-11-04
ATR	0.58
Beta	1.55
Beta1y	5.69
Beta2y	1.73
Ch YTD	-3.85
High	8.23
High52	9.82
High52 Date	2025-11-28
High52ch	-18.64%
Low	7.72
Low52	3.28
Low52 Date	2025-11-04
Low52ch	143.6%
Ma50ch	34.56%
Price vs 200-day SMA	35.52%
RSI	67.74
RSI Monthly	39.87
RSI Weekly	58.54
Sharpe ratio	1.1x
Sortino ratio	2.03
Total Return	-105.61%
Tr YTD	-3.85
Tr1m	37.29%
Tr1w	27.43%
Tr3m	15.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.59
Earnings Revenue Estimate	4,556,000x
Earnings Revenue Estimate Growth	32.48x
Operating Income	$-11.9M
Operating margin	-33.56
Price target	$17
Price Target Change	$113

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,777,375%
Float Percent	39.45%
Net Borrowing	-48,202,000
Shares Insiders	29.17%
Shares Institutions	18.32%
Shares Out	17,178,786
Shares Qo Q	48.68%
Shares Yo Y	105.61%
Short Float	8.58%
Short Ratio	5.3
Short Shares	3.38

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.9M
Average Volume	99,958.55x
Bv Per Share	1.44
Ch1m	37.29
Ch1w	27.43
Ch1y	95.45
Ch3m	15.63
Ch3y	-87.8
Ch5y	-93.05
Ch6m	130.9
Change	-3.03%
Change From Open	-2.44
Close	8.24
Days Gap	-0.61
Depreciation Amortization	485,000
Dollar Volume	881,856.3
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-11.9M
EBITDA	$-11.5M
EPS	$-1.68
F Score	4
FCF	$-17.6M
FCF EV Yield	-16.21x
FCF Per Share	$-1.03
Financing CF	1,445,000
Fiscal Year End	December
Founded	2,013
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Date	2025-07-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-11
Ma150	6.06
Ma150ch	31.85%
Ma20	6.66
Ma20ch	19.97%
Net CF	-16,182,000
Next Earnings Date	2026-05-12
Open	8.19
Optionable	No
Position In Range	52.94
Post Close	7.99
Postmarket Change Percent	-2
Postmarket Price	$7.83
Ppne	1,862,000
Price Date	2026-05-08
Ptbv Ratio	5.55
Relative Volume	1.1x
Revenue	35,577,000x
SBC By Revenue	9.33x
Share Based Comp	3,318,000
Tr6m	130.93%
Us State	Pennsylvania
Volume	110,370
Z Score	-7.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VRCA pay a dividend?

Capital-return profile for this ticker.

Performance

VRCA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VRCA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.3%

Float: +39.5% of shares outstanding

Insider ownership

+29.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VRCA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.7

Neutral momentum band

Price vs 200-day MA

+35.5%

50/200-day relationship not available

Beta (5Y)

1.55

More volatile than the market

Sharpe ratio

1.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VRCA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VRCA stock rating?

Verrica Pharmaceuticals Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VRCA analysis?

The full report lives at /stocks/VRCA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VRCA?

The latest report frames VRCA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VRCA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.